Présentation de l’Huile CBD 20% Full Spectrum 10mL

Huile CBD 20% Full Spectrum 10mL – Qualité CBD Suisse

SWISS MEDICAL CANNABIS SA. has selected the best hemp genetics from the European catalog and produced in organic culture.

L’huile CBD 20% est confectionnée à partir de cannabinoïdes extraits au CO2 supercritique. Cette méthode d’extraction permet de conserver une qualité et une pureté parfaite de l’ensemble du spectre des cannabinoïdes (faisant partie des huiles considérées comme « Full spectrum »).

Our extractions are tested and contain no heavy metals or other pollutants. All our oils are 100% organic, guaranteed without pesticides or herbicides. We use the term "organic" because some of our flower production is done indoors, which prevents us from claiming the organic label because of the use of electric lights.

Also our products are 100% vegetable origin and are not tested on animals, so they can benefit from the claim of "vegan" products.

Bienfaits des ingrédients de l’Huile CBD 20% Full Spectrum 10mL

L’huile CBD 20% SMC Laboratories® est composée d’éléments naturels de la plante

Cannabis Sativa L.including the different phytocannabinoids: Cannabidiol (CBD), Cannabichromene (CBC), Cannabigerol (CBG)and Cannabinol (CBN).

It also contains terpenes, including myrcene, limonene, alpha and beta pinene, linalool, B-caryophyllene, caryophyllene oxide, humulene, nerolidol and phytol.

L’huile CBD 20% contient d’autres molécules naturelles : alcanes, composés azotés, aminoacides, sucres, aldéhydes, cétones, flavonoïdes, glucosides, vitamines, pigments et est stabilisée dans de l’huile de graines de chanvre.

Taux de THC : < 0,2% conformément aux réglementations en vigueur.

Utilisation Huile CBD 20 % Full Spectrum 10mL

Our company SWISS MEDICAL CANNABIS SA. is subject to the various legislations, Swiss and European, formally prohibiting to praise the benefits of cannabis and its derivatives. We are therefore not in a legal position to give you medical advice or recommendations for use.

On the other hand, you can learn more about the generalities about cannabinoids in theCBD Blog section of our website.

All our articles are written by our team of experts on cannabinoids and their applications. The facts transcribed through our CBD Blog are taken from the international scientific literature, whose sources are verifiable and quoted at the end of each of our articles by following the link below:

Our cosmetic products are for skin application only, they do not have any biocidal effect, nor do they have curative, lenitive or preventive properties, such as medicinal or therapeutic properties, nor do they have disinfectant or anti-inflammatory effects, nor are they recommended by a member of the medical profession. Do not ingest cosmetic products. SWISS MEDICAL CANNABIS SA. declines all responsibility for the misuse of its products.

1 Goutte = 10mg de CBD

1 ml = 20 Drops

1 Bottle = 10ml = mini 200 Drops

Ex : Si 2 Gouttes à 20% / jour = 20mg = 100 jours d’utilisation.

Store in a cool & dry place and use within 6 months after opening.

The CBD oils of classification "Chemical product" contain an additive making them unfit for consumption. Therefore, we do not sell them.

They are specifically designed to meet the highest standards of Health Professionals.

The "CBD oils" products of our company SWISS MEDICAL CANNABIS SA. benefit from Pharmacodes for parapharmaceutical products, intended for final consumers. Referenced by the company HCI SOLUTION, these Pharmacodes attest to the respect of good procedures for the marketing of our products. Our CBD oils can be freely sold by health professionals to their customers.

All these data are the property of SWISS MEDICAL CANNABIS SA. It is the property of SWISS MEDICAL CANNABIS SA. and is protected by the 91/250/EEC and 96/9/EC directives, which respectively grant copyright protection to computer programs and databases. SWISS MEDICAL CANNABIS SA. reserves the right to take legal action competent in connection with any copying or reproduction of our information. We also reserve the right to bring an action for damages, in accordance with Article L. 331-1-3 of the CPI, which states that "to determine the damages, the court shall take into consideration the negative economic consequences, including loss of earnings, suffered by the injured party, the profits made by the author of the infringement of rights and the moral prejudice caused to the owner of these rights as a result of the infringement.